Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Follow-up of Patients With Talocalcaneal Coalitions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04950361
Recruitment Status : Completed
First Posted : July 6, 2021
Last Update Posted : July 6, 2021
Sponsor:
Information provided by (Responsible Party):
Peking University Third Hospital

Brief Summary:
The objective of this study was to develop a new classification system based on the articular facets involved to cover all coalitions and guide operative planning.

Condition or disease Intervention/treatment
Talocalcaneal Coalition Other: talocalcaneal coalition

Detailed Description:
Patients were diagnosed with talocalcaneal coalition using a CT scan, between January 2009 and February 2021. We classified the coalition into four main types according to the shape and nature of the coalition: I, inferiorly overgrown talus or superiorly overgrown calcaneus; II, both talus and calcaneus overgrew; III, coalition with an accessory ossicle; (I-III types are non-osseous coalition) IV, complete osseous coalition. Then each type was further divided into three subtypes according to the articular facets involved. A, the coalition involving the anterior facets; M, the coalition involving the middle facets, and P, the coalition involving the posterior facets.

Layout table for study information
Study Type : Observational
Actual Enrollment : 106 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Follow-up of Patients With Talocalcaneal Coalitions
Actual Study Start Date : January 1, 2009
Actual Primary Completion Date : January 31, 2020
Actual Study Completion Date : June 10, 2021

Intervention Details:
  • Other: talocalcaneal coalition
    patients with talocalcaneal coalition


Primary Outcome Measures :
  1. CT [ Time Frame: pre-surgery ]
    computerized tomography scan


Secondary Outcome Measures :
  1. MRI [ Time Frame: pre-surgery ]
    magnetic resonance imaging

  2. AFOAS [ Time Frame: pre-surgery, one year after sugery ]
    he American Orthopaedic Foot & Ankle Society score

  3. Tegner [ Time Frame: pre-surgery, one year after sugery ]
    the Tegner score



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients that were diagnosed with talocalcaneal coalition using a CT scan, between January 2009 and February 2021.
Criteria

Inclusion Criteria:

  • Patients diagnosed as talocalcaneal coalition by CT or MRI at the outpatient
  • Underwent arthroscopic talocalcaneal coalition resection due to failure of conservative treatment

Exclusion Criteria:

  • The affected side underwent other foot and ankle operations
  • Combined with other ankle diseases
  • Refused to participate in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04950361


Sponsors and Collaborators
Peking University Third Hospital
Investigators
Layout table for investigator information
Study Chair: Qinwei Guo, MD Peking University Third Hospital
Layout table for additonal information
Responsible Party: Peking University Third Hospital
ClinicalTrials.gov Identifier: NCT04950361    
Other Study ID Numbers: M2020197
First Posted: July 6, 2021    Key Record Dates
Last Update Posted: July 6, 2021
Last Verified: June 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No